Company filings profile · CIK 0001808805
Nautilus Biotechnology, Inc. — SEC filings & insider activity.
Real, source-linked SEC EDGAR activity for Nautilus Biotechnology, Inc. (NAUT): 8 filings in the last 90 days vs 13 in the prior 90 (filing-velocity cooling ↓ · 0.62×). Latest material 8-K events, insider Form-4 transactions, and periodic reports — monitored for change.
✔ Verified against the public SEC EDGAR filing record as of Jun 21, 2026. Source-linked, daily-refreshed.
Material 8-K events — Nautilus Biotechnology, Inc.
8-K disclosures decoded by item code (the material events: agreements, results, control/management changes, impairments, restatements).
| Filed | Event | |
|---|---|---|
| Jun 18, 2026 | Item 5.07 | ↗ |
| Apr 28, 2026 | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Feb 26, 2026 | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Nov 4, 2025 | Other Events | ↗ |
| Oct 28, 2025 | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Jul 31, 2025 | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Jun 23, 2025 | Item 5.07 | ↗ |
| May 2, 2025 | Delisting / Listing-Rule Failure | ↗ |
Watch Nautilus Biotechnology, Inc. automatically
Add this company to a watchlist and get a webhook/email the moment it files a material 8-K, an insider Form 4, or changes its risk-factor language.
Insider transactions (Form 4 / 3 / 5)
Recent filings
| Filed | Form | Detail | |
|---|---|---|---|
| Jun 18, 2026 | 8-K | Item 5.07 | ↗ |
| Jun 4, 2026 | SCHEDULE 13D/A | ↗ | |
| Jun 4, 2026 | 4 | ↗ | |
| Apr 28, 2026 | ARS | ARS | ↗ |
| Apr 28, 2026 | DEFA14A | DEFA14A | ↗ |
| Apr 28, 2026 | DEF 14A | DEF 14A | ↗ |
| Apr 28, 2026 | 10-Q | 10-Q | ↗ |
| Apr 28, 2026 | 8-K | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Mar 4, 2026 | SCHEDULE 13D/A | ↗ | |
| Mar 4, 2026 | SCHEDULE 13D/A | ↗ | |
| Mar 4, 2026 | 4 | FORM 4 | ↗ |
| Mar 4, 2026 | 4 | FORM 4 | ↗ |
| Mar 4, 2026 | 4 | FORM 4 | ↗ |
| Mar 4, 2026 | 4 | FORM 4 | ↗ |
| Mar 4, 2026 | 4 | FORM 4 | ↗ |
| Mar 4, 2026 | 4 | FORM 4 | ↗ |
| Mar 4, 2026 | 4 | FORM 4 | ↗ |
| Mar 4, 2026 | 4 | FORM 4 | ↗ |
| Feb 26, 2026 | S-8 | S-8 | ↗ |
| Feb 26, 2026 | 10-K | 10-K | ↗ |
| Feb 26, 2026 | 8-K | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Nov 10, 2025 | 4 | FORM 4 | ↗ |
| Nov 4, 2025 | 8-K | Other Events | ↗ |
| Oct 28, 2025 | 10-Q | 10-Q | ↗ |
| Oct 28, 2025 | 8-K | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Sep 9, 2025 | 4 | FORM 4 | ↗ |
| Sep 5, 2025 | 4 | FORM 4 | ↗ |
| Jul 31, 2025 | 10-Q | 10-Q | ↗ |
| Jul 31, 2025 | 8-K | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Jun 25, 2025 | 4 | FORM 4 | ↗ |
| Jun 25, 2025 | 4 | FORM 4 | ↗ |
| Jun 25, 2025 | 4 | FORM 4 | ↗ |
| Jun 25, 2025 | 4 | FORM 4 | ↗ |
| Jun 25, 2025 | 4 | FORM 4 | ↗ |
| Jun 24, 2025 | SCHEDULE 13D/A | ↗ | |
| Jun 23, 2025 | 8-K | Item 5.07 | ↗ |
| Jun 2, 2025 | 4 | FORM 4 | ↗ |
| May 12, 2025 | 4 | FORM 4 | ↗ |
| May 2, 2025 | 8-K | Delisting / Listing-Rule Failure | ↗ |
| Apr 29, 2025 | ARS | ARS | ↗ |